Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nicotine use increases compulsive alcohol consumption, study finds

  • Major vascular anomalies found in brains of people with Huntington's disease

  • Cancer and chemobrain: Cancer diagnosis affects cognitive function

  • Epilepsy drug may preserve eyesight for people with multiple sclerosis

  • Should they stay or should they go? Study finds no harm from hospital policies that let families observe CPR

  • Difficult to break the soda habit? Sugar-sweetened beverages suppress body's stress response

  • Electronic micropump to deliver treatments deep within the brain

  • Increasing evidence points to inflammation as source of nervous system manifestations of Lyme disease

  • Scientists use brain stimulation to boost creativity, set stage to potentially treat depression

  • Botox makes unnerving journey into our nervous system

  •